BSX

Boston Scientific Corporation (BSX)

Last Price$98.70.5%
Market Cap$145.3B
LTM Net Debt to Free Cash Flow
4.5x
5Y avg
8.2x
Medical - Devices industry median
0.3x
Stock quality & Intrinsic value

Boston Scientific Corporation Net Debt to Free Cash Flow

Annual
Quarterly
LTM
Industry median
Company stand-alone
BSX
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Net Debt to Free Cash Flow
0.5x
2.1x
4.8x
11.8x
6.0x
10.7x
111.2x
5.7x
3.9x
4.8x
3.6x
15.2x
8.9x
4.9x
(1,151.7x)
7.3x
6.9x
5.7x
9.1x
5.1x
BSX
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BSX and see if it's the right time to invest.
Dive in

Boston Scientific Corporation (BSX) Net Debt to Free Cash Flow comparison analysis

Crunching data... Almost there!

BSX key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Boston Scientific Corporation's Net Debt to Free Cash Flow?

As of today, Microsoft Corp's last 12-month Net Debt to Free Cash Flow is 4.5x, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Net Debt to Free Cash Flow for Boston Scientific Corporation have been 7.3x over the past three years, and 8.6x over the past five years.

2) Is Boston Scientific Corporation's Net Debt to Free Cash Flow Good?

As of today, Boston Scientific Corporation's Net Debt to Free Cash Flow is 4.5x, which is higher than industry median of 0.3x. It indicates that Boston Scientific Corporation's Net Debt to Free Cash Flow is Bad.

3) How does Boston Scientific Corporation's Net Debt to Free Cash Flow compare to its peers?

As of today, Boston Scientific Corporation's Net Debt to Free Cash Flow is 4.5x, which is higher than peer median of 1.7x. The list of peers includes ZBH, MDT, SYK, STE, PODD, ABT, DXCM, ALGN, PHG, EW.